122 related articles for article (PubMed ID: 38389206)
1. Pluvicto-Induced 18 F-PSMA PET Bone Flare.
Wang X; Martin D; Hogan T; Veselicky K
Clin Nucl Med; 2024 Apr; 49(4):342-343. PubMed ID: 38389206
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Flare on [
Malaspina S; Ettala O; Tolvanen T; Rajander J; Eskola O; Boström PJ; Kemppainen J
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):613-621. PubMed ID: 36161511
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hybrid
Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
[TBL] [Abstract][Full Text] [Related]
5. Total-Body
Pomykala KL; Czernin J; Grogan TR; Armstrong WR; Williams J; Calais J
J Nucl Med; 2020 Mar; 61(3):405-411. PubMed ID: 31541035
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
Aggarwal R; Wei X; Kim W; Small EJ; Ryan CJ; Carroll P; Cooperberg M; Evans MJ; Hope T
Eur Urol Oncol; 2018 May; 1(1):78-82. PubMed ID: 31100231
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients.
Uslu-Beşli L; Sağer S; Akgün E; Asa S; Şahin OE; Demirdağ Ç; Güner E; Khosroshahi BR; Karayel E; Pehlivanoğlu H; Aygün A; Uslu İ; Talat Z; Sönmezoğlu K
Turk J Med Sci; 2019 Feb; 49(1):301-310. PubMed ID: 30761859
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT.
Lawal I; Vorster M; Boshomane T; Ololade K; Ebenhan T; Sathekge M
Clin Nucl Med; 2015 Sep; 40(9):755-6. PubMed ID: 26053729
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
11. A Multicenter Prospective Clinical Trial of
McCarthy M; Francis R; Tang C; Watts J; Campbell A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):801-808. PubMed ID: 30890448
[TBL] [Abstract][Full Text] [Related]
12. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis.
Chow KM; So WZ; Lee HJ; Lee A; Yap DWT; Takwoingi Y; Tay KJ; Tuan J; Thang SP; Lam W; Yuen J; Lawrentschuk N; Hofman MS; Murphy DG; Chen K
Eur Urol; 2023 Jul; 84(1):36-48. PubMed ID: 37032189
[TBL] [Abstract][Full Text] [Related]
13. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R
Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451
[TBL] [Abstract][Full Text] [Related]
14. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
Simsek DH; Sanli Y; Civan C; Engin MN; Isik EG; Ozkan ZG; Kuyumcu S
Ann Nucl Med; 2020 Jul; 34(7):476-485. PubMed ID: 32394269
[TBL] [Abstract][Full Text] [Related]
15. Application of [
Dadgar H; Emami F; Norouzbeigi N; Vafaee MS; Jafari E; Gholamrezanezhad A; Assadi M; Ahmadzadehfar H
Mol Imaging Biol; 2020 Aug; 22(4):1062-1069. PubMed ID: 31758511
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A
Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559
[TBL] [Abstract][Full Text] [Related]
17. Diffuse bone metastases on (68)Ga-PSMA PET-CT in a patient with prostate cancer and normal bone scan.
Lavalaye J; Kaldeway P; van Melick HH
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1563-4. PubMed ID: 27121692
[TBL] [Abstract][Full Text] [Related]
18. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of
Esen B; Seymen H; Tarim K; Koseoglu E; Bolukbasi Y; Falay O; Selçukbiricik F; Molinas Mandel N; Kordan Y; Demirkol MO; Tilki D; Esen T
Eur Urol Focus; 2023 Sep; 9(5):832-837. PubMed ID: 37032281
[TBL] [Abstract][Full Text] [Related]
20. Intraindividual Comparison of
Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]